AIV Logo AIV Assistant

Loading...

 Logo Ryman Healthcare Limited - RH7.F Open Ryman Healthcare Limited in new tab

1.41 EUR
EPS
-0.31
P/B
0.33
ROE
-10.91
Beta
0.30

1.4060 EUR

1.406 EUR

Daily: +1.01%
Key Metrics

Earnings date: May 28, 2025

EPS: -0.31

Book Value: 4.20

Price to Book: 0.33

Debt/Equity: 40.14

% Insiders: 14.068%

Growth

Revenue Growth: 0.11%

Earnings Growth: -0.50%

DCF Valuation

Tweak assumptions to recompute fair value for Ryman Healthcare Limited (RH7.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Ryman Healthcare Limited - (RH7.F)

Country: New Zealand

Sector: Health Care

Website: http://www.rymanhealthcare.co.nz

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, as well as a care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.

Historical Dividends
Year Total Dividends
2022 0.20 EUR
2021 0.20 EUR
2020 0.19 EUR
2019 0.21 EUR
2018 0.19 EUR
2017 0.17 EUR
2016 0.15 EUR
2015 0.13 EUR
2014 0.06 EUR

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion